Pitiriga Vassiliki, Campos Elsa, Bakalis John, Sagris Konstantinos, Georgiadis George, Saroglou George, Tsakris Athanasios
Department of Microbiology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Street, Athens, 11527, Greece.
Department of Internal Medicine, Metropolitan Hospital, 9 Ethnarchou Makariou Street, Piraeus, Neo Faliro, 18547, Greece.
Antimicrob Resist Infect Control. 2025 Jun 20;14(1):70. doi: 10.1186/s13756-025-01590-x.
Understanding the impact of catheter dwell time on the risk of central-line associated bloodstream infections (CLABSIs) is crucial to developing effective infection prevention strategies. The aim of the study was to evaluate the relationship between catheter dwell time and the risk of CLABSIs caused by multidrug-resistant and common pathogens in patients with central venous catheters (CVCs) and peripherally inserted central catheters (PICCs).
We retrospectively analysed data from patients admitted consecutively to a tertiary care Greek hospital from 2018-2020. Events were categorized into three groups based on 10-days' intervals: group 1 (≤ 10 days), group 2 (11-20 days), and group 3 (> 21 days).
Α total of 84 patients (mean age 56.4 ± 19.6 years) were included in the study. Among them, 62 (73.8%) had CVC, while 22 (26.2%) had PICC placement. In the CVC cohort, a statistically significant difference in CLABSI rates was observed, with rates of 4.49, 5.57, and 8.54 per 1,000 catheter/days for groups 1, 2, and 3 respectively (p < 0.001). Similarly, higher rates of MDROs were found in group 3, with rates of 2.93, 3.71, and 4.47 per 1,000 catheter/days for groups 1, 2, and 3, respectively (p = 0.01). Regarding the PICC cohort, significant differences in CLABSI rates were observed among the three groups, with rates of 0.93, 2.25, and 1.67 per 1,000 catheter/days for groups 1, 2, and 3, respectively (p < 0.001).
Our results emphasize the critical role of catheter selection and duration management in mitigating CLABSI risk, especially for patients with CVCs.
了解导管留置时间对中心静脉导管相关血流感染(CLABSI)风险的影响对于制定有效的感染预防策略至关重要。本研究的目的是评估中心静脉导管(CVC)和外周静脉穿刺中心静脉导管(PICC)患者的导管留置时间与多重耐药菌和常见病原体引起的CLABSI风险之间的关系。
我们回顾性分析了2018年至2020年连续入住一家希腊三级护理医院的患者数据。根据10天的间隔将事件分为三组:第1组(≤10天)、第2组(11 - 20天)和第3组(>21天)。
共有84例患者(平均年龄56.4±19.6岁)纳入本研究。其中,62例(73.8%)有CVC,而22例(26.2%)进行了PICC置管。在CVC队列中,观察到CLABSI发生率有统计学显著差异,第1组、第2组和第3组的发生率分别为每1000导管日4.49、5.57和8.54例(p<0.001)。同样,第3组中多重耐药菌的发生率更高,第1组、第2组和第3组的发生率分别为每1000导管日2.93、3.71和4.47例(p = 0.01)。关于PICC队列,三组之间观察到CLABSI发生率有显著差异,第1组、第2组和第3组的发生率分别为每1000导管日0.93、2.25和1.67例(p<0.001)。
我们的结果强调了导管选择和留置时间管理在降低CLABSI风险中的关键作用,特别是对于CVC患者。